iRhythm Technologies, Inc. financial data

Symbol
IRTC on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
699 8 Th Street, Suite 600, San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Oct 30, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 553 % +96.8%
Quick Ratio 14.7 % -10.4%
Debt-to-equity 573 % +522%
Return On Equity -128 % -176%
Return On Assets -19 % +21.3%
Operating Margin -26.9 % -19.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31.3M shares +2.11%
Common Stock, Shares, Outstanding 31.3M shares +2.14%
Entity Public Float 3.2B USD 0%
Common Stock, Value, Issued 31K USD 0%
Weighted Average Number of Shares Outstanding, Basic 31.3M shares +2.14%
Weighted Average Number of Shares Outstanding, Diluted 31.3M shares +2.14%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 560M USD +18.5%
Cost of Revenue 180M USD +20.3%
Research and Development Expense 68.4M USD +30%
Operating Income (Loss) -151M USD -41.2%
Nonoperating Income (Expense) 4.31M USD +532%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -150M USD -43.8%
Income Tax Expense (Benefit) 669K USD +17.8%
Net Income (Loss) Attributable to Parent -151M USD -43.6%
Earnings Per Share, Basic -4.85 USD/shares -40.6%
Earnings Per Share, Diluted -4.85 USD/shares -40.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 520M USD +994%
Marketable Securities, Current 2.5M USD -97.8%
Cash, Cash Equivalents, and Short-term Investments 165M USD +28.8%
Accounts Receivable, after Allowance for Credit Loss, Current 77.4M USD +54.6%
Inventory, Net 15M USD +10.1%
Assets, Current 628M USD +168%
Property, Plant and Equipment, Net 122M USD +26.6%
Operating Lease, Right-of-Use Asset 45.6M USD -25.2%
Goodwill 862K USD 0%
Other Assets, Noncurrent 45.5M USD -3.21%
Assets 910M USD +107%
Accounts Payable, Current 7.59M USD +5.28%
Accrued Liabilities, Current 74M USD -3.49%
Contract with Customer, Liability, Current 3.03M USD -10.4%
Liabilities, Current 100M USD -2.14%
Operating Lease, Liability, Noncurrent 74M USD -9.43%
Other Liabilities, Noncurrent 18M USD +1675%
Liabilities 838M USD +281%
Accumulated Other Comprehensive Income (Loss), Net of Tax -66K USD -340%
Retained Earnings (Accumulated Deficit) -758M USD -24.8%
Stockholders' Equity Attributable to Parent 71.8M USD -67.3%
Liabilities and Equity 910M USD +107%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -52M USD -69.2%
Net Cash Provided by (Used in) Financing Activities 505M USD +55661%
Net Cash Provided by (Used in) Investing Activities 40M USD +947%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 31.5M shares +2.88%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 493M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 528M USD +1012%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.6M USD +135%
Deferred Tax Assets, Valuation Allowance 218M USD +15.8%
Deferred Tax Assets, Gross 230M USD +8.28%
Operating Lease, Liability 89.5M USD -7.49%
Payments to Acquire Property, Plant, and Equipment 9.78M USD +16.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -151M USD -44.6%
Lessee, Operating Lease, Liability, to be Paid 116M USD -10.9%
Property, Plant and Equipment, Gross 188M USD +31.7%
Operating Lease, Liability, Current 15.5M USD +3.03%
Lessee, Operating Lease, Liability, to be Paid, Year Two 16.1M USD -25.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 15.6M USD -28.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 26M USD -20.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 16.5M USD -22.6%
Deferred Tax Assets, Operating Loss Carryforwards 128M USD +14.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 5.77M USD +22%
Lessee, Operating Lease, Liability, to be Paid, Year Four 16.4M USD -21.5%
Operating Lease, Payments 3.2M USD
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 20.2M USD +34.7%
Deferred Tax Assets, Net of Valuation Allowance 12.1M USD -50.1%
Share-based Payment Arrangement, Expense 83.8M USD +21.2%
Interest Expense 5.56M USD +81.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%